“Biotech is becoming increasingly important to the mainstream chemical industry as the demand for more sustainable solutions intensifies. Biotech is especially well-suited to help with some of the industry’s biggest challenges”. To say it – in this exclusive interview with Il Bioeconomista – is Christophe Schilling, founder and CEO of Genomatica, a widely-recognized bioengineering leader for the chemical industry. The San Diego-based biotechnology company develops and licenses bio-based manufacturing processes for the production of intermediate and basic chemicals.
Since being named CEO in May 2009, Christophe Schilling has led Genomatica to widespread recognition as a leader in industrial biotechnology, with a commercialized first process, top-tier licensees, strong investors and an unrivaled string of awards for engineering (Kirkpatrick), science (EPA Presidential Green Chemistry), industry leadership (voted #1 Hottest three years in a row by Biofuels Digest), and company culture (The Scientist as a Best Place to Work). Schilling frequently speaks on industry trends at major conferences and serves as a member of the World Economic Forum Global Agenda Council on Biotechnology.
Interview by Mario Bonaccorso
Yesterday, at COP22, in Marrakech (Morocco), a coalition of leading countries in the clean energy and the bioeconomy fields announced the launching of the Biofuture Platform, a new collective effort to accelerate development and scale up deployment of modern sustainable low-carbon alternatives to fossil based solutions in transport fuels, industrial processes, chemicals, plastics and other sectors.
Global Bioenergies, the French biotech company that is developing a process to convert renewable resources into hydrocarbons through fermentation, announced yesterday that the construction of its demo plant, started mid-2015, is completed.
IL BIOECONOMISTA 